Skip to content

Coexistence of Allergic diseases and proinflammatory cytokine in inflammatory bowel disease(IBD) and irritable bowel syndrome(IBS)

Coexistence of Allergic diseases and proinflammatory cytokine in inflammatory bowel disease(IBD) and irritable bowel syndrome(IBS) - Coexistence of Allergic diseases and proinflammatory cytokine in IBD and IBS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026256
Enrollment
400
Registered
2017-02-21
Start date
2017-03-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease (IBD) ,irritable bowel syndrome (IBS) and healthy subjects

Interventions

None listed

Sponsors

Kawasaki Medical School
Lead Sponsor
Kouseikai Medical Corporation
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with inflammatory bowel disease and irritable bowel syndrome. And healthy subjects.

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

MeasureTime frame
Coexsistense of allergic diseases and proinflammatory cytokine profiles in IBS,IBD and healthy subjects

Countries

Japan

Contacts

Public ContactManabu Ishii

Kawasaki Medical School Gastroenterology Department of Internal Medicine

manabuisii@niji.or.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026